Results 31 to 40 of about 3,814,825 (281)
BMC Ophthalmology, 2023 Background The role of anticoagulation or antiplatelet on post-vitrectomy vitreous hemorrhage (POVH) in patients with proliferative diabetic retinopathy (PDR) is rarely investigated in the small-gauge vitrectomy era.
Meng Zhao +3 more
doaj +1 more source
Systemic antiplatelet agents and anticoagulants in eyes with branch retinal vein occlusion
Therapeutic Advances in Ophthalmology, 2021 Purpose: The purpose of this study was to investigate the effect of systemic antiplatelet agents and anticoagulants on the structural and functional outcomes of eyes with branch retinal vein occlusion (BRVO).
Pali P. Singh +7 more
doaj +1 more source
Novel agents for anti-platelet therapy
Journal of Hematology & Oncology, 2011 Anti-platelet therapy plays an important role in the treatment of patients with thrombotic diseases. The most commonly used anti-platelet drugs, namely, aspirin, ticlopidine, and clopidogrel, are effective in the prevention and treatment of cardio ...
Ji Xuebin, Hou Ming
doaj +1 more source
Efficacy and safety of various antithrombotic regimens after left atrial appendage occlusion
Кардиоваскулярная терапия и профилактика, 2022 Aim. To evaluate the efficacy and safety of various antithrombotic regimens after left atrial appendage occlusion (LAAO) in real clinical practice.Material and methods.
D. V. Pevsner +3 more
doaj +1 more source
Current Antiplatelet Treatment Strategy in Patients with Diabetes Mellitus [PDF]
Diabetes & Metabolism Journal, 2015 Patients with diabetes mellitus (DM) have accelerated atherosclerosis with an increased risk for atherothrombotic cardiovascular complications. A state of high platelet reactivity and activation, hypercoagulability (prothrombotic state) and a subdued ...
Jung Hwa Jung +3 more
doaj +1 more source
Platelet-Derived Extracellular Vesicles as Target of Antiplatelet Agents. What Is the Evidence?
Frontiers in Pharmacology, 2019 Platelet-derived large extracellular vesicles (often referred to as microparticles in the field of cardiovascular disease) have been identified as effector in the atherothrombotic process, therefore representing a target of pharmacological intervention ...
F. Taus +3 more
semanticscholar +1 more source
Anaesthesia Critical Care & Pain Medicine, 2019 BACKGROUND Patients on either antiplatelet or anticoagulant therapy may need procedures performed under peripheral nerve blocks in preference to general anaesthesia techniques.
F. Joubert +5 more
semanticscholar +1 more source
Location‐Specific Hematoma Volume Predicts Early Neurological Deterioration in Supratentorial ICH
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective Early neurological deterioration (END) adversely affects outcomes in patients with intracerebral hemorrhage (ICH). This study aimed to determine the location‐specific hematoma volumes for END in supratentorial ICH patients. Methods We retrospectively analyzed supratentorial ICH patients presenting from two prospective cohorts.
Zuoqiao Li +10 more
wiley +1 more source
Pharmacogenetics of Antiplatelet Drugs
The Scientific World Journal, 2002 Pharmacogenetics refers to the genetic factors that influence the response to a drug, often involving genetic variations in drug metabolizing enzymes. The pharmacogenetics of antiplatelet agents is in its infancy and largely reflects variations in drug ...
Ronan Curtin, Desmond J. Fitzgerald
doaj +1 more source
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Introduction/Objective Acute intracranial stenting during endovascular thrombectomy (EVT) for ischemic stroke requires intraprocedural antiplatelet therapy (APT) to maintain patency. However, the hemorrhagic risk of combining APT with intravenous thrombolysis (IVT) remains uncertain.
Aaron Rodriguez‐Calienes +75 more
wiley +1 more source